Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants
Abstract Data is lacking on the effect of continuous intravenous sildenafil treatment in preterm infants with early pulmonary hypertension (PH), especially in very low birth weight (VLBW) infants. Preterm infants (< 37 weeks of gestational age) with intravenous sildenafil treatment and diagnosis...
Main Authors: | Lukas Schroeder, Paulina Monno, Brigitte Strizek, Till Dresbach, Andreas Mueller, Florian Kipfmueller |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-35387-y |
Similar Items
-
Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension
by: Lukas Schroeder, et al.
Published: (2023-02-01) -
Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
by: Kacie Dillon, et al.
Published: (2023-08-01) -
Short term effect of intravenous treprostinil in term and preterm infants with pulmonary hypertension
by: Yoo-Jin Kim, et al.
Published: (2024-01-01) -
Sildenafil in the treatment of pulmonary hypertension
by: O. S. Groznova, et al.
Published: (2016-03-01) -
Comparison of intravenous sildenafil with inhaled nitric oxide for acute vasodilator testing in pulmonary arterial hypertension
by: Shine Kumar, et al.
Published: (2022-10-01)